ISPUB.com / IJHE/3/1/10332
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Hematology
  • Volume 3
  • Number 1

Original Article

Haematological Profile of Male Rats Treated with Ethanol and/ or Chloroquine and fed Normal or Low Protein Diet

E Mbajiorgu, T Aire, W Volk, M Albert, L Debusho

Keywords

chloroquine, ethanol, heamatology, protein-energy malnutrition

Citation

E Mbajiorgu, T Aire, W Volk, M Albert, L Debusho. Haematological Profile of Male Rats Treated with Ethanol and/ or Chloroquine and fed Normal or Low Protein Diet. The Internet Journal of Hematology. 2006 Volume 3 Number 1.

Abstract

Chloroquine (Q) is widely used as the main drug for malaria therapy in malaria endemic regions of the world, especially in Africa. Individuals on Q therapy frequently consume alcohol (E), in the face of protein malnutrition. This study was designed to evaluate the effects of chloroquine and/or ethanol treatment on haematological values of male Sprague-Dawley rats placed on normal protein (NP, 15%) or on low protein (LP, 6%) diet (malnutrition) for 40 days divided into 4 equal intervals. After 10 days of treatment, 5 - 7 rats were randomly selected from each rat cohort and sacrificed. This was repeated for 4 consecutive intervals. Haematological values were lower in LP than in NP-treated rats during all intervals. Ethanol or Q treatments generally depressed haematopoiesis and produced significant reductions in the values of some of the haematological parameters, viz Rbc, Hb, PCV, MCV, MCH and platelets, irrespective of the dietary protein status. However, the reduction in these parameters due to Q was less in NP-treated rats. Ethanol-low protein treatment (LPE) caused significant elevations (P<0.001) in MCHC values at all intervals except at Day 30. Ethanol and Q interactively enhanced haematopoiesis in NPEQ and LPEQ rat cohorts and caused general and significant increases in the values of some of the haematologic parameters. The greater increases in haematological values of NPEQ than in LPEQ-treated rats, suggests a modulating effect by nutritional status on the effects of these drugs - individually and in combination - on haematopoiesis. A significantly strong interaction (p<0.0001) was found between the drug effects, the sampling intervals and the dietary status.


Total white blood cell count was significantly (p<0.05) increased in the LPE and LPQ-treated rats. The variations in leukocyte counts were essentially caused by variations in neutrophil and lymphocyte numbers. The gradual increases in neutrophil and lymphocyte counts across the intervals in all treated groups reflect a stressful condition impacted upon the immune system. The interaction between the drugs in NPEQ- and LPEQ-rat cohorts resulted in reductions in the lymphocyte and neutrophil counts, suggesting a lowering of immune status of the animals.

 

Introduction

Chloroquine is a 4-aminoquinoline drug that is used widely for prophylaxis and treatment of malaria [1]. Despite the world-wide parasitic resistance to chloroquine [2, 3], it has remained the drug of choice in the management of plasmodiasis [4]. In malaria-endemic areas, some individuals on chloroquine treatment or prophylaxis for malaria consume alcohol regularly [5].

The interaction of chloroquine with some drugs has been shown to either potentiate or attenuate the effects of such drugs [5, 6, 7, 8]. There is only one report on the interaction of chloroquine with ethanol [5]. However, concurrent consumption of chloroquine and ethanol in the face of protein malnutrition is prevalent in much of the third world, and therefore may constitute a very serious health problem. The present communication reports haematological changes that are associated with the concurrent intake of alcohol, chloroquine and normal or low protein diets by adult male Sprague-Dawley rats.

Materials And Methods

Experimental animals

Adult male Sprague-Dawley rats (≥ 3 months in age), body weight 150.5g to 300g, were used in the study. The rats were bred, housed and maintained at the Animal House, Faculty of Medical Sciences, University of Zimbabwe. The rats were housed in a fly-proof accommodation and maintained on a 12–hour light / 12-hour dark regiment. The cages were designed such that the experimental rats were housed in the upper compartment while their faeces and urine pass straight to a lower compartment filled with saw dust thereby preventing any contamination of the rats. Further Laboratory and data analysis were carried out at the University of Limpopo.

Experimental Design

The rats were randomly assigned to two major groups based on their dietary protein status: Normal protein diet (NP; 14.94%) and low protein diet (LP; 6.19%) groups – see Table 1 for composition and proximate analysis of the feed. Each diet group of rats was further sub-divided into four sub-groups of 20 to 28 rats each that received either vehicles only (ie. normal protein control- NPC; low protein control-LPC), or chloroquine (normal protein chloroquine-NPQ; low protein chloroquine- LPQ), or ethanol (normal protein ethanol-NPE; low protein ethanol-LPE), or both (normal protein ethanol and chloroquine-NPEQ; low protein, ethanol and chloroquine-LPEQ). The rats were on the treatments for either 10, or 20, or 30 or 40 days (d). The intervals were selected in an attempt to monitor the pattern of changes in the treatment effects. Food and water were provided ad libitum and all the animals were placed on the appropriate diet one week before the experiment began.

Chloroquine (10mg/kg body weight per rat) was administered intramuscularly, on days 0, 10, 20, and 30 to the NPQ, LPQ, NPEQ and LPEQ groups while 6% alcohol in drinking water was provided ad libitum to the NPE, LPE, NPEQ and LPEQ groups as described by Nolan et al. [9] and Akingbemi and Aire [10]. Drinking water, being the vehicle for ethanol, was given to the groups on only chloroquine treatment (NPQ; LPQ) while saline, the vehicle for chloroquine, was injected to the groups receiving only ethanol (NPE; LPE). At the interval of ten days (d), after each of the chloroquine injections (10, 20, 30 and 40d), 5 to 7 rats were randomly selected from each of the eight treatment groups, weighed, deeply anaesthetized, and then sacrificed. The blood was collected by cardiac puncture into sterile tubes containing K-EDTA following the method of Akingbemi and Aire [10] and then appropriately labeled to reflect the treatment groups as well as the intervals of the study.

Haematological Techniques

All the blood samples were subjected to complete blood cell count. Leucocyte (WBC) and erythrocyte (RBC) counts were done on an electronic cell counter (Coulter, UK). The haemoglobin (Hb) and haematocrit (PCV) values were determined by the cyanomethaemoglobin and microhaemotocrit methods respectively, with the commercial Zap-o-Globin Reagent (Coulter Electronics, Republic of South Africa [RSA]). All other erythrocyte indices – mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), and the mean corpuscular haemoglobin concentration (MCHC) were calculated from the haematological data obtained. The platelet count and differential leucocyte counts were determined as described by Jain [11].

Data presentation and statistical analysis

The descriptive statistical analysis was done using SPSS 12.0. The data were further subjected to a 2 x 4 2 factorial analysis of variance using the statistical software, statistica 6.1. Values are presented as means ± SEM. All the treated groups were compared with the controls (i.e. NPC) at various intervals. The nutritional effect was assessed by comparing the groups with similar treatment but placed on different diets. The interactive analysis involving the treatments, diets and the intervals was also carried out. Student's t-test was used to test for differences in all the comparisons. A value of p < 0.05 was considered significant.

Ethical consideration:

Ethical clearance for this study was obtained from the Ministry of Agriculture, Zimbabwe, as stipulated in the Scientific Animal Experiment Act, 1963. Additionally, the SPCA staff made frequent inspections of the animals and their experimental room environment. The University of Limpopo ethical committee also approved the study.

Results

All animals were in good bodily condition throughout the experiment. There were no physical or behavioral changes and unplanned deaths recorded throughout the experiment. The haematological values were obtained from the rats treated with E, and/ or Q and fed either NP or LP diet.

Interactive effects

The values were generally significantly lower in LP- than in NP-treated rats across the intervals. The interaction of E, and Q with LP and NP diets for 40 days had significant effects (p < 0.001) in almost all the parameters considered except in RBC, eosinophil and monocyte counts (Table 4). Low protein diet exacerbated the effect of this interaction. The increased RBC count in concurrent administration in the NPEQ- and LPEQ- treated rats (Fig. 1) points to increases in erythropoiesis.

Figure 1
Figure 1: Shows the RBC counts of rats treated with ethanol and / or chloroquine and fed normal or low protein diet.

The increase was more in NPEQ-treated rats. Accordingly Hb concentration was significantly increased (p < 0.05) in NPEQ- (significant at 10; 30d), but generally reduced in LPEQ- treated rats (Table 2). Generally, E and Q, interactively significantly elevated (p < 0.01) PCV value in NPEQ- (beneficial drug interaction) but, reduced (p < 0.01) it in LPEQ-treated rats (adverse drug interaction) (Fig. 2).

Figure 2
Figure 2: Shows the effects of ethanol and/ or chloroquine treatment over time on PCV value of rats fed normal or low protein diet.

The MCV values were generally lower in NPEQ- and LPEQ- treated rats relative to their E or Q treated cohorts, evident at 40d (Fig. 3).

Figure 3
Figure 3: Shows the effects of ethanol and/ or chloroquine treatment over time on MCV value of rats fed normal or low protein diet.

From 30 to 40d, the MCV values while being gradually increased in NPEQ group, was gradually decreased in LPEQ group (Fig. 3). It also showed strong interaction between intervals, drugs and diets (Table 4).

Figure 4
Table 1: Composition of experimental diets in percentages and the proximate analysis

Figure 5
Table 2: The effects of ethanol, chloroquine and both on some haematological indices of rats fed normal or low protein diet

Figure 6

Values are given as mean ± s.e.m, Values in the same row with different superscripts (alphabets) from NPC (controls) are significantly different from NPC.

Values in the row with the same superscripts *(asterisks) are not significantly different from NPC.

Significance levels = a (p < 0.05), b (p < 0.01), c (p < 0.001), d (p < 0.0001)

Values in the same row with superscript † indicates significant dietary effect on a particular treatment (i.e. NPC/LPC, NPE/LPE etc)

Figure 7
Table 3: The leukocyte count and differential leukocyte analysis of rats treated with ethanol and / chloroquine and fed low or normal protein diet.

Figure 8

Values are presented as means ± s.e.m. (x10 9 ). n = no. of animals

Values in the same row with different superscripts (alphabets) from NPC (controls) are significantly different from NPC.

Values in the row with superscripts *(asterisks) are not significantly different from NPC. Significance levels = a (p < 0.05), b (p < 0.01), c (p < 0.001), d (p < 0.0001)

Values in the same row with superscript † indicates significant dietary effect on a particular treatment (i.e. NPC/LPC, NPE/LPE etc)

Figure 9
Table 4: The level of significance of the analysis of variance on the interaction of ethanol and/ chloroquine on some haematological indices of rats fed low or normal protein diet.

The interaction generally depressed MCH values in NPEQ- and LPEQ- groups relative to other treatment groups but, from 30 to 40d led to elevated values in NPEQ group against a gradual decrease in LPEQ group. While E and Q interactively antagonize each other in LPEQ-treated rats and produce MCHC value that was midway between that of LPE and LPQ at 40d, further reductions was recorded in NPEQ-treated rats at all intervals relative to other groups (Table 2). The strong significant interaction between the drugs, diet and intervals existed despite fluctuations in platelet count across the intervals (Table 4). Slightly elevated platelet values were found in NPEQ- and LPEQ- groups relative to their E and Q cohorts. Leukocytosis caused by E and Q treatments, were interactively reduced in LPEQ- and NPEQ-treated rats (Table 3). Since no significant change was observed in eosinophil and monocyte counts (Table 3), the interaction between interval and treatments, interval and dietary regimens, treatment and dietary regimens and between the three (interval × treatment × diet) was not significant for monocytes and eosinophils, but highly significant for neutrophils and for lymphocytes, except in the interaction between treatment x feed, and interval x feed for lymphocytes only (Table 4).

RBC

The numbers of RBC were significantly decreased (P < 0.05) in the LPC and NPE (10; 20d respectively), LPE (10; 30d), NPQ (20d) and LPQ (10 to 40d) groups relative to their respective interval control (NPC) as shown in Table 2. Low protein diet significantly decreased (P < 0.05) the numbers of RBC in LPC (10; 20d), LPE, LPQ (10; 30d) and LPEQ (10d) groups relative to their respective NP cohort as shown in Table 2.

Hb.

The haemoglobin concentrations were significantly decreased (P < 0.05) in the LPC (20; 40d), NPE (10; 20)d, LPE (10 to 40d), NPQ (20d), LPQ (10; 20; 30d), NPEQ (20d) and LPEQ (10 to 40d) groups in comparison with the respective interval controls (Table 2). Low protein diet significantly reduced Hb concentration in LPC (20; 40d), LPE (10 to 40d), LPQ (10 to 30d), and LPEQ (10 to 40d) groups compared against their NP cohorts (Table 2).

PCV

Normal protein intake probably increased erythropoiesis at 30d and 40d and reversed the significantly depressed PCV value by E and Q treatment (NPE, 10 & 20d; NPQ 20d). The increased erythropoiesis was more in NPE-treated rats hence the significant increases in PCV values (20 and 30d), but normalized for both drugs at 40d (Fig. 2). Low protein intake exacerbated the depressive effects of E and Q in (LPE-) and significantly (p < 0.01) in LPQ-treated rats at 40d. Irrespective of the dietary status, Q seems to have slightly more reductive effect than E. Low protein diet significantly reduced (P < 0.05) PCV in LPC (20; 40d), LPE, LPQ and LPEQ (10 to 40d) compared against their NP cohorts (Table 2).

MCV

The MCV values were significantly reduced (p < 0.05) during all the intervals in LPC, LPE, LPQ and LPEQ groups, NPE (10 to 30d), NPQ (10; 20d) and NPEQ (10 to 30d) in comparison with respective interval control (NPC) (Table 2). Significant elevations (p < 0.05) were however recorded in the NPE and NPQ groups at 40d. Low protein diet alone or in combination with ethanol and /or chloroquine significantly (p < 0.05) decreased MCV values during all intervals in comparison with their respective NP cohorts (Table 2).

MCH

In comparison with the respective interval controls, MCH values were significantly (p < 0.5) reduced in LPC, LPE and NPEQ (10 to 30d), NPE (10d), NPQ (10; 20d), LPQ and LPEQ (10 to 40d). However, LPC and LPE respectively showed significant increases (p < 0.05) in MCH value at 40d (Table 2). Low protein diet significantly reduced MCH value in LPC, LPQ (10 to 40d), LPE (10 to 30d), and LPEQ (10; 40d) against their NP cohorts (Table 2).

MCHC

The MCHC were significantly elevated (p < 0.05) in LPC and LPQ (20; 40d), LPE (10; 20; 40d) and LPEQ (10 to 40d), while significant reductions (p < 0.05) in MCHC were noted in LPC (30d), NPE (40d), NPEQ (10 to 40d) when compared with their respective interval control (NPC) as shown in Table 2. Low protein diet significantly increased MCHC in LPC (20 to 40d), LPE and LPEQ (10 to 40d), LPQ (10; 40d) groups relative to their respective NP cohorts (Table 2).

Platelets

Platelet counts significantly (p < 0.05) decreased in LPC (40d), NPE and NPQ (20; 40d), LPE (10; 20; 40d), LPQ and NPEQ (40d) in comparison with the respective interval controls (Table 2). Low protein diet significantly decreased (p < 0.05) platelet counts in LPC (40d), LPE and LPEQ (10d respectively), but significant increase in LPE (30d) and LPQ (20d) groups, in comparison with their NP cohorts was observed.

Total And Differential WBC Count

The results of WBC and differential counts are presented in Table 3. The counts were generally slightly higher in the LP-treated rats. However, gradual increases between intervals were observed in NPEQ- and LPEQ-treated rats.

The WBC count was significantly (p < 0.05) increased in LPC (10; 30; 40d), NPE (40d), LPE (20 to 40d), LPQ (10; 20; 40d), NPEQ (40d) and LPEQ (30; 40d) groups when compared with the respective interval controls (Table 3). Low protein diet significantly (p < 0.05) increased WBC count in LPC (10; 30; 40d), LPE (10 to 30d), LPQ (10; 20; 40d), and LPEQ (40d) groups of rats relative to their NP-treated cohorts (Table 3). Significant increases in lymphocyte count occurred in LPC (40d), LPE (20; 40d), and LPQ (40d) groups of rats in comparison with the respective control groups (NPC; Table 3). Also LP diet significantly increased lymphocyte count in LPC (40d), LPE (20 to 40d), LPQ (10; 20; 40d) and LPEQ (10; 20d) in comparison with their NP cohorts (Table 3). Neutrophil count increased significantly in LPE and LPQ (30d respectively) when compared with the control at this interval (Table 3). Low protein diet significantly increased neutrophil count in LPC (40d), LPE (10; 30d) and LPQ (30; 40d) when compared against their paired NP-treated cohorts (Table 3). Low protein diet significantly increased eosinophil count in LPE and LPEQ (10d respectively) and monocyte count in LPQ (10d to 30) and LPEQ (10d) when compared against their NP-treated groups (Table 3).

Discussion

General

The increase in the interactive effect of E and Q by LP-diet is similar to that reported by Akingbemi and Aire [10] on the interaction between gossypol and ethanol in normal and low protein fed-rats. High dietary protein intake increases metabolism of drugs and the activity of the mixed function oxidase system, and consequently increases the excretion of the drugs [12], while inadequate protein intake results in reduced metabolism [13, 14, 15] and therefore increased toxic effects of the drugs. The fluctuations in treatment effects in all the parameters suggest changes in the biotransformation or bioavailability of the drugs across the intervals. The similarity in trend across the intervals in the values of RBC, Hb and PCV agrees with the report of Johnson et al. [15]. The changes produced in RBC indices by E, Q and their interaction under NP- and LP-intake implicates a tendency toward low Hb and small cells. Perhaps microcytic anemia may develop if the treatment continued for a longer duration.

As previously reported by Harold and Ballard [16], the reductions in RBC count in both dietary regimens by E and Q suggests a depression of haematopoietic process. However, both drugs interactively altered their individual adverse effects on the haematopoietic system leading to increased erythropoiesis (Fig. 1). The increase was more amongst the NPEQ-treated rats. Musabayane et al. [5] have reported an interactive effect of E and Q, whereby E and Q separately significantly reduced urinary Na + excretion but, in combined administration, significantly increased its excretion. This study has shown that Q may be directly toxic to the haematopoietic system as also reported by Nagaratnam et al. [17]. Since E is also directly toxic to the haematopoietic system [16], the enhancement of haematopoiesis, as the available literature suggests, may be a combination of one or more of the following: (a) alteration of renally active hormones [5], (b) increased metabolism and excretion of both drugs due to high protein intake [12], (c) a metabolic induction (interaction) via cytochrome P-450 enzymes ([18] i.e. metabolic or biological antagonism between E and Q leading to increased activity of P-450 enzymes (increased clearance) [19, 20, 21]. This could result in diminished or absence of the activities of both drugs, and (d) a deficiency of protein, essential amino acids and several minerals also decreases the activity of this system in animal tissues [22, 23].

The elevated Hb concentration due to the interaction between E and Q in NPEQ-treated rats is consistent with increased RBC production in this group of rats. Also the increased Hb concentration in NPE and NPQ as against LPE and LPQ-treated rats may be supported by previous reports that protein rich diets increased both haematocrit levels and haemoglobin concentrations in human and animal studies [24]. The effect of E and Q therefore are related to the dietary lines. Low protein intake may have marred the interactive effects of E and Q thereby exacerbating a decrease in heme production [25] and haematopoiesis [16] as reflected in LPEQ-treated rats.

The changes in PCV values suggest that dietary protein levels and probably treatment duration may modulate the effects of E and Q on PCV values. Since PCV levels reflect the extent and efficiency of oxygen uptake and transfer to tissues [26], the low values in LPEQ-treated rats may reflect low oxygen uptake and transfer to tissues, signifying a reduction in the body's metabolic activity [27].

The macrocytic effect of E became evident at 40d in normal nutritional status. While this finding agrees with previous reports [16, 28, 29], it further suggests that duration of treatment may be a factor. It has been suggested that macrocytosis caused by E may be due to direct toxic effects of E and its metabolites on the haematopoietic system [30, 31, 32]. In this study, Q was found to cause macrocytosis under normal protein dietary conditions at 40d. The macrocytosis in NP- and microcytosis in LP- treated groups at 40d, suggest the influence of nutritional status on the effects of E and Q on peripheral blood. This may also explain the strong interaction between intervals, drugs and diets (Table 4). The result at 40d in NPEQ- group relative to NPQ- and NPE- groups indicate that Q interaction with E ameliorates macrocytosis in NP- dietary regimen. Generally, E suppresses haematopoiesis [33, 34] and impairs the function of the haematopoietic system [35], our findings suggest further depression of these systems in conditions of low protein-energy intake by both drugs.

The general reduction over time in MCH values in all the treatment groups implicates different levels of anemic conditions. The greater reduction (p<0.01) in LP-fed rats indicates greater severity of effects in low protein intake. The convergent/reductive effects of E and Q in the NP-fed rats (NPE, 30, 40d and NPQ 30, 40d) and the divergent/reductive effects in the LP-fed rats (LPE, 30, 40d and LPQ, 30, 40d) may reveal phases of drug effects and stress on the body's homeostasis as the treatment progressed. It suggests that interaction between the drugs and other metabolic processes may be involved. The pronounced difference in MCH values of NPEQ- and LPEQ-treated rats at 40d, suggest a modification of drug action, enhanced by the duration of treatment and influence of dietary regimen as already explained, above.

The increased MCHC in LP-treated rats (LPE, LPQ and LPEQ) suggests a hyperchromic anemia, a condition commonly associated with a decrease in number and increase in size and haemoglobin content of RBCs. The general reduction in RBC number may have caused the accumulation of haemoglobin within the available RBCs, while the decreased MCHC values, especially in NPE and NPEQ, may be due to the greater number of RBCs in comparison to LPE- and LPEQ-treated rats. The effects of the treatment on other haematologic parameters may have also contributed to the MCHC profile.

At 40d, thrombocytopenia was present in all treatments irrespective of dietary status. Ethanol-induced thrombocytopenia may be due to its interference with the late stage of platelet production [16,32,36], possibly due to a combination of ineffective thrombocytopoiesis and a shortened platelet life span or both [25]. The increases in circulating platelets in LPE (thrombocytosis) suggest an initial response to toxic effects of E, while the decrease from 30 to 40d may indicate a time-dependent effect with a consequent decrease in haematopoiesis [16]. Low protein-intake exacerbated thrombocytopenia caused by Q as reflected in LPQ treated group at 40d. The present finding conflicts with the report of Osim et al. [37] that Q prolongs the life span of platelets by inhibiting platelet aggregation thereby increasing the number of circulating platelets without any effect on bleeding time [38] but agrees with other reports that Q causes thrombocytopenia [39]. Interactively both drugs acting antagonistically produced less adverse effect in NPEQ- and LPEQ-treated rats.

The higher WBC counts in the LP- than the NP-treated suggests that adequate nutrition is essential in stabilizing the immune system of the body [13] in the presence of these drugs [40]. The leukocytosis (LPE and LPQ), less severe in NPE and absent in NPQ groups, suggests that nutrition modulates the effects of both drugs. The gradual but consistent leukocytotic effect (more in LPEQ than in NPEQ group) due to the interaction between E and Q may indicate a gradual development of a pathological condition, with Q and E consistently ameliorating the effect of each other through the intervals, as suggested by the significant interaction between the drugs, diets and intervals.

Eosinophil and monocyte counts did not contribute to the change in the total WBC count observed in the treatment groups irrespective of the nutritional status, as no significant change in count was observed. Since neutrophils and lymphocytes have a major role in fighting foreign organisms, the variations in leukocyte counts were essentially caused by variations in neutrophil and lymphocyte numbers.

The neutrophilia across the intervals in all the treatment groups reflect stress increases on the immune system. With high level of pathogen fighting cells in the LP-treated rats, the immune system seem to be more challenged in this group, and consequently the significant increase in lymphocyte count at 40d in LPC, 30d in LPE and LPQ-treated rats. The interaction between the drugs in the E- Q-treated rats resulted in reduction in the lymphocyte and neutrophil counts, suggesting a lowering of resistance to infectious agents.

Conclusion

There is a strong significant interaction between E, Q, dietary status and duration of treatment on haematologic values. The depressive effects of E and Q, individually, on haematopoiesis is gradual but may become marked with time, even in the absence of protein malnutrition. The individual adverse effects of E, Q, and diet seem to be biologically altered in concurrent administration. Further studies will attempt to determine the probable mechanism of action involved.

Acknowledgement

We acknowledge with thanks the Department of Anatomy, University of Zimbabwe, in allowing me to use the laboratory facilities and the assistance of the laboratory staff during the experimental stage of this work.

Correspondence to

Ejikeme F. Mbajiorgu Department of Medical Sciences School of Health sciences University of Limopo Private Bag, X1106 Sovenga 0727 Limpopo Province South Africa. E-mail: ejifun@gmail.com; ejifun@hotmail.com. Phone : ++27 82 200 5189 (cell) ; ++27 268 3281 (office) ; ++27 268 2205 (fax)

References

1. Sofola AO, Olube ID, Adegoke F: The effects of chronic chloroquine toxicity on blood pressure in rats. J Trop Med Hyg 1981; 84: 249 - 252.
2. Wernsdorfer WH: The development and spread of drug-resistant malaria. Parasitol. Today 1991; 7(11): 297 - 303.
3. Bray PG, Ward SA: Malaria Chemotherapy: Resistance to quinoline containing drugs in Plasmodium falciparum. FEMS - Microbiol Lett 1993; 113(1): 1 - 8.
4. Magwere T, Naik YS, Hasler JA: Effects of chloroquine treatment on antioxidant enzymes in rat liver and kidney. Free radical Biology and Medicine 1997; 22(1/2): 321 - 327.
5. Musabayane CT, Cooper RG, Osim EE, and Balment RJ: Renal electrolyte and fluid handling in the rat following chloroquine and/or ethanol administration. General Pharmacol 2000; 34: 43 - 51.
6. von Schmiedeberg S, Ronnau AC, Schuppe HC, Specker C, Ruzicka T, Lehmann P: Combination of antimalarial drugs mepacrine and chloroquine in therapy refractory cutaneous lupus erythematosus. Hautarzt 2000; 51(2): 82 - 5.
7. Famin O, Ginsburg H: Differential effects of 4-aminiquinoline-containing antimalarial drugs, on hemoglobin digestion in plasmodium falciparum-infected erythrocytes. Biochemical Pharmocol 2002; 63(3): 393 - 398.
8. Chen Tso-Hsiao, Po-Chiao C, Mon-Chiu C, Yuan-Fong L, Horng-Mo L: Chloroquine induces the expression of inducible nitric oxide synthase in C6 glioma cells. Pharmocol Res 2005; 51(4): 329 - 336.
9. Nolan CJ, Bestervelt LL, Mousigian CA, Maimansomuk P, Cai Y, and Piper WN: Chronic ethanol consumption depresses hypothalamic - pituitary - adrenal function in aged rats. Life Sciences 1991; 49: 1923 - 1928.
10. Akingbemi BT, Aire TA: Haematological and serum biochemical changes in the rat due to protein malnutrition and gossypol - ethanol interactions. J Comp Path 1994; 111: 413 - 426.
11. Jain WC: Schalm's Veterinary Hematology, ed 4, Lea and Febiger, Philadelphia. 1986, pp. 69 - 71.
12. Hatchcock JN: Metabolic mechanisms of drug-nutrient interactions. Federation of American Societies for Experimental Biology proceedings 1985; 44: 124 - 129.
13. Blackburn HD, Rocha JL, Figueiredo EP, Berne ME, Vieira LS, Cavalcante AR, Rosa JS: Interaction of parasitism and nutrition in goats: effects on haematological parameters, correlation, and other statistical associations. Veterinary Parasitology 1992; 44: 183 - 197.
14. Chang YL, Sohn HS, Chan KC, Berdanier CD, Hargrove JL: Low dietary protein impairs blood coagulation in BHE/cdb rats. J Nutr 1997; 127(7): 1279 - 83.
15. Johnson Q, Veith WJ, Mouton T: The impact of dietary protein intake on serum biochemical and haematological profiles of vervet monkeys. J Med Primatol 2001; 30: 61 - 69.
16. Harold S, Ballard MD: The haematological complications of alcoholism. Alcohol Health Res World 1997; 21: 42 - 52.
17. Nagaratnam N, Chetiyawardana AD, Rajiyah S: Aplasia and leukaemia following chloroquine therapy. Postgraduate Med J 1978; 54: 108 - 112.
18. Rollof J, Vinge E: Nerologic adverse effects during concomitant treatment with ciprofloxacin, NSAIDS, and chloroquine: possible drug interaction. Ann Pharmacother 1993; 27(9): 1058 - 9.
19. Lewis Fd: In: Cytochromes P450, structure, function, mechanism. Taylor & Francis Ltd. 1997, pp 169 - 210.
20. Pelkonen O, Maenpaa J, Taavistsainen P, Raunio H: Inhibition and induction of human cytochrome P450 (CYO) enzymes. Xemobiotica 1998; 12: 1203 - 1253.
21. Whitlock JP: Induction of cytochrome P450 IAI. Annual Rev Pharmacol and Toxicol 1999; 39: 103 - 125.
22. Hartshorn EA: Food and drug interactions. J Am Diet Assoc 1977; 70: 15 - 19.
23. Ariens EJ, Simonis AM: General principles of nutritional toxicology. Hathcock JN. (ed): Nutritional toxicology. 1982, Vol 1, NY Academy pp 17 - 80
24. Alada ARA, Akande OO, Ajayi FF: Effects of soya bean diet preparation on some haematological and biochemical indices in the rat. Afr J Biomed Res 2004; 7(2): 71 - 74.
25. Lindenbaum J: Hematologic complications of alcohol abuse. Semin Liver Dis 1987; 7: 167 - 181.
26. Ots I, Murumagi A, Horak P: Haematological health state indices of reproducing Great Tits: methodology and sources of natural variation. Functional Ecology 1998; 12: 700 - 707.
27. Carpenter FL: Bird hematocrits\; effects of high altitude and strength of flight. Comparative Biochem Physiol 1975; 50A: 415 - 417.
28. Savage DG, Ogundibe A, Allen RH, Stabler SP, Lindenbaum J: Etiology and diagnostic evaluation of macrocytosis. Am J Med Sci 2000; 319: 343 - 352.
29. Cook DJ: Biochemical markers of alcohol use in pregnant women. Clin Bioche 2003; 39: 9 - 19.
30. Meagher RC, Sieber F, Spivak JL: Suppression of haematopoietic-progenitor-cell proliferation by ethanol and acetaldehyde. N Engl J Med 1982; 30: 845 - 9.
31. Levine RF, Spivak JL, Meagher RC, Sieber F: Effect of ethanol on thrombosis. Br J Maematol 1986; 62: 345 - 54.
32. Niemela O, Parkkila S: Alcoholic macrocytosis - is there a role for acetaldehyde and adducts? Addiction Biology 2004; 9: 3 - 10.
33. Sullivan LW, Herbert V: Suppression of Haematopoiesis by ethanol. J clin Invest 1964; 43: 2048 - 2062.
34. Balkaya M, Unsal H, Unsal C, Kargin F, Dabanoglu I: Effect of alcohol and passive smoking on some haematological variable of Swiss Albino mice. Turk J Vet Anim Sci 2005; 29: 241 - 250.
35. Mørland H, Mørland B: Different effects of ethanol on particle phagocytosis via dufferent receptors in human monocytes. APMIS 1989; 97: 853 - 857.
36. Lindenbaum J, Hargrove RL: Thrombocytopenia in alcoholics. Ann Internal Med 1968; 68(3): 526 - 532.
37. Osim E, Mudzingwa S, Musabayane C, Mbajiorgu F, Munjeri O: The effects of chloroquine on circulating platelet survival in the rat. J Cardiovasc Pharmacol Therapeut 1999; 4 (2): 97 - 102.
38. Osim E, Mbajiorgu F, Nkomo I, Coutts A, Munjeri O, Vaz R. Arthur S, Musabayane C: The effects of chloroquine on bleeding time and disappearance of platelet 5-hydroxytryptamine in rabbits. J Cardiovasc Pharmacol Therapeut 2000; 5 (3): 1 - 6.
39. Cherylann UZ, Lawande D, Bagga AS: Rifampicin induced thrombocytopenia. Ind J Tub 1995; 42: 173 - 175.
40. Szabo G: Monocytes, alcohol use and altered immunity. Alcohol Clin Exp Res 1998; 5: 216S - 219S.

Author Information

E. F. Mbajiorgu, M.Sc.
Department of Medical Sciences, University of Limpopo

T. A. Aire, Ph.D.
Department of Veterinary Anatomy, University of Pretoria

W. Volk, Ph.D.
Department of Zoology, University of Limpopo

M. Albert, D.Sc.
Department of Medical Sciences, University of Limpopo

L. K. Debusho, Ph.D.
Department of Statistics, University of Limpopo

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy